Multiple Manufacturers

Paclitaxel

Manufacturer:

Multiple Manufacturers

Paclitaxel HCPCS:

J9267

HCPCS Code Descriptor:

Injection, paclitaxel, 1 mg

Category:

J Code

Paclitaxel NDCs:

63323-0763-50, 63323-0763-52, 70860-0200-50, 00703-3218-01, 00703-3218-81, 62332-0622-50, 44567-0506-01, 16714-0137-01, 61703-0342-50, 00703-3217-01, 68001-0516-27, 47781-0595-07, 63323-0763-17, 63323-0763-16, 62332-0621-17, 70860-0200-17, 70860-0215-68, 67457-0434-51, 00703-3216-81, 00703-3216-01, 44567-0505-01, 61703-0342-22, 70860-0215-67, 62332-0620-05, 67457-0449-17, 70860-0200-05, 63323-0763-06, 63323-0763-05, 00703-3213-81, 00703-3213-01, 61703-0342-09, 70860-0215-66, 67457-0471-52

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

23155-0884-31, 23155-0883-31, 23155-0882-31, 63323-0763-52, 70860-0200-50, 44567-0506-01, 47781-0595-07, 63323-0763-17, 70860-0200-17, 70860-0215-68, 67457-0434-51, 44567-0505-01, 70860-0215-67, 67457-0449-17, 70860-0200-05, 63323-0763-06, 70860-0215-66, 67457-0471-52

About Paclitaxel:

Paclitaxel is an Oncology drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J9267 is aligned to the drug Paclitaxel.

ACCESS PRICING AND MORE BY REGISTERING

J9267 Added Date:

January 1, 2015

J9267 Effective Date:

January 1, 2015

J9267 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Paclitaxel billing and coding information.
Our team did not identify a source for Paclitaxel patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for Paclitaxel
Our team has not yet identified a source of side effects information for Paclitaxel. Please check back in a few weeks.